ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Sanofi

Sanofi (1SAN)

96.58
1.88
(1.99%)
Closed 10 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
96.58
Bid
94.80
Offer
97.70
Volume
762
95.29 Day's Range 96.70
84.98 52 Week Range 107.96
Market Cap
Previous Close
94.70
Open
95.29
Last Trade
20
@
96.58
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
854
Shares Outstanding
1,252,640,466
Dividend Yield
3.89%
PE Ratio
22.34
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 94.70 €. Over the last year, Sanofi shares have traded in a share price range of 84.98 € to 107.96 €.

Sanofi currently has 1,252,640,466 shares in issue. The market capitalisation of Sanofi is 118.63 € billion. Sanofi has a price to earnings ratio (PE ratio) of 22.34.

1SAN Latest News

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma New Sarclisa subcutaneous formulation met co-primary endpoints in the...

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple

Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a satisfait aux co-critères d’évaluation primaires de l’étude de phase III IRAKLIA dans le myélome multiple La nouvelle...

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines

Press Release: Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi initiates phase 3 program for...

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins pneumococciques conjugués

Communiqué de presse : Sanofi lance un programme de phase III pour son vaccin VPC21 et élargit sa collaboration avec SK Bioscience afin de développer une nouvelle génération de vaccins...

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors

Presse release: Jean-Paul Kress to join Sanofi's Board of Directors Jean-Paul Kress to join Sanofi's Board of Directors Paris, December 19, 2024. Sanofi's Board of Directors is pleased to...

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi

Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Jean-Paul Kress rejoint le Conseil d’administration de Sanofi Paris, le 19 décembre 2024. Le Conseil...

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn

Communiqué de presse : Les résultats positifs de phase IIb concernant le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de...

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease

Press Release: Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Duvakitug positive phase 2b results demonstrate best-in-class...

Press Release: Availability of the Q4 2024 Aide-mémoire

Press Release: Availability of the Q4 2024 Aide-mémoire Availability of the Q4 2024 Aide-mémoire Paris, France – December 17, 2024. Sanofi announced today that its Q4 2024 Aide-mémoire is...

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire »

Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » Mise en ligne du document « Q4 2024 Aide-mémoire » Paris, France, le 17 Décembre 2024. Sanofi annonce la mise en ligne...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.982.0930232558194.696.792.9155994.50028275DE
45.345.8526961858891.2496.787.4893591.83468173DE
12-3.82-3.80478087649100.4101.687.4885493.70997721DE
263.954.26427723292.63107.9687.4886696.40274758DE
521.671.7595616900294.91107.9684.9884393.19831737DE
1567.788.7612612612688.8107.9676.3696391.72346755DE
2604.154.4898842367292.43107.9668147187.81816371DE

1SAN - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 96.58 €
How many Sanofi shares are in issue?
Sanofi has 1,252,640,466 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 118.63B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 84.98 € to 107.96 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 22.34
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 2.8
What is the reporting currency for Sanofi?
Sanofi reports financial results in EUR
What is the latest annual turnover for Sanofi?
The latest annual turnover of Sanofi is EUR 43.07B
What is the latest annual profit for Sanofi?
The latest annual profit of Sanofi is EUR 5.4B
What is the registered address of Sanofi?
The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WERFOLaboratorio Farmaceutico Erfo SPA
0.075 €
(31.58%)
1.5k
WNUS26Nusco Spa
0.129 €
(28.10%)
11.81k
BESBestbe Holding
0.60 €
(21.95%)
94.89k
ELBEdgelab
7.14 €
(20.61%)
45.5k
1SKBKoenig & Bauer AG
16.02 €
(16.93%)
30
EVAAAAskoll Eva AA
0.0002 €
(-99.41%)
1.17M
WSAC25Saccheria Flli Franceschetti SpA
0.018 €
(-25.00%)
11.9k
WTFINTrevi Finanziaria Industriale Spa
0.701 €
(-22.11%)
13
WPAL26Palingeo SpA
0.24 €
(-16.08%)
4.8k
EVAAskoll Eva SPA
0.131 €
(-11.19%)
807.5k
TITTelecom Italia SpA
0.258 €
(0.00%)
150.34M
ISPIntesa Sanpaolo Spa
3.9875 €
(0.49%)
44.81M
TITRTelecom Italia
0.2993 €
(-0.30%)
24.57M
ENELEnel Spa
7.041 €
(0.77%)
23.56M
SPMSaipem Spa
2.753 €
(1.36%)
20.21M

Discussion

View Full Feed
MiamiGent MiamiGent 2 minutes ago
Wow!
w6w9t8015 w6w9t8015 3 minutes ago
I wonder if we ever hear anything on Eco again? The Transfer was supposed to happen in august
WBSR
tw0122 tw0122 3 minutes ago
EYEN
nyt nyt 3 minutes ago
What's the deal....is there no trading today?
VPLM
CrashOverride CrashOverride 3 minutes ago
Does Adam Feuerstein think he will get away with the manipulation on 5/09/2022?

https://x.com/flaskworks/status/1877372280554013069?t=-ON4f8eeuZe9qFOpa3KBag&s=19
NWBO
3331 3331 3 minutes ago
WRONG AGAIN!

EVERY great stock has been beaten down at some point, if not many times. The biggest money is made when these stocks are bought at the bottom. BIEL is one good contract away, and that could be Taiwan, VA, veterinary, etc.

"The lies and BS on this MB a
BIEL
tw0122 tw0122 4 minutes ago
1/6  style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: -apple-system; font-size: 15px"  style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: -apple-system; font-size: 15px"-- Eyenovia (EYEN) said Monday it is exploring strategic alternatives for its bu
EYEN
nowwhat2 nowwhat2 4 minutes ago
I'll assume you meant "Clonkish".........You MUST HAVE meant "Clonkish".....
What given since that's what it's done ;

https://investorshub.advfn.com/uimage/uploads/2025/1/9/xoyuuBTC_!_8_6m_11am_THRU_HORIZ_DIAG_SNIPS_.jpg



Yes - Down to The Red Ova
XRPUSD
TightCoil TightCoil 4 minutes ago
"A watched pot never boils"
FNMA
MiamiGent MiamiGent 4 minutes ago
Insurers will take a bath. Good short.
bigworld bigworld 4 minutes ago
https://finance.yahoo.com/news/key-us-treasury-yields-approach-134001674.html?guccounter=1&guce_referrer=aHR0cHM6Ly9jaXRpemVuZnJlZXByZXNzLmNvbS8&guce_referrer_sig=AQAAAGrEVLXA_SPEZT3l9G6CxZJFfO9AIVzM9XQhAMw5qjvcks1RjdM4veZLCLwdJPQl9E6dL9Dui9OhNXWlqyLKBUE9aBdglbx8SFGzb58OxcYzozx1gEmRHNEttOC15N_GXcad4
tw0122 tw0122 4 minutes ago
EYEN
bigworld bigworld 4 minutes ago
gfp: that was one of my favorite songs back in the day. I saw Marshall Tucker a couple of times at big music festivals. They were a terrific band.
ToucanYoucan ToucanYoucan 4 minutes ago
$RGLG - Maybe I'm the weirdo, but when I completely sell out of a position, I don't hang around and post about it. I feel like I have better things to do. But, hey - that's just me.

We continue to get nice updates from management going forward here! Hoping FINRA can start getting s
RGLG
facts_matter14 facts_matter14 5 minutes ago
Bag holders: Don’t worry about no CES after Maxine played you again.

The future for POSRMX is very bright, as you can see from this fake image of what appears to be a terrible looking product 17, in an even more terrible looking location.

Ask Can It B why she couldn’t h
SRMX
StayHumble StayHumble 5 minutes ago
w0w Xcellent💹 Kramers 100% Involved💹 Billions Naked short ?

It explains the situation about shorting and naked shorting perfectly!

Again, this is a MUST WATCH video for anyone who believes in $DBMM (naked or otherwise)!

I'd love to h
DBMM
doc2016 doc2016 5 minutes ago
countries want nvidia......japan, southamerica, usa, uk/eu/russia...south africa/brazil/etc.

cuda-q.......
NVDA
JTORENCE JTORENCE 5 minutes ago
ison929 Why shouldn't they be open??
NWBO
Nogobeaver Nogobeaver 5 minutes ago
Why cant one find a place to purchase SGTM products?

If you google Humisoil first thing that comes up is A1 organtics. They were the US dist for VRM before SGTM.

I see no place to actualy purchase the products yet they claim to have $100 million in inventory???
SGTM
Viking61 Viking61 6 minutes ago
Jog, I always sleep with one eye open. My glass eye just works that way😂
FNMA
SLC-JD SLC-JD 6 minutes ago
Irrespective of whether you have a case, you wouldn't be able to collect on any judgement.

The Company is insolvent, and all of its assets have been sold. BK proceedings are currently trying to determine who the proceeds of the asset sale should go to (mostly a fight between Drexler
MSLPQ
fza fza 7 minutes ago
there are many like myself that bought back in 2010 and 2011 who are no longer here or around
Trust me there are not many like you.
I’m not trying to sound dark or morbid
Oh yeah, I bet you are a barrel laughs at a funeral or wake.
I bought my shares as cheap as they g
KBLB
doc2016 doc2016 8 minutes ago
aws spending 10 billion in georgia for ai
dubai and mantra blockchain to tokenize realworld assets using proof of stake, therefore brave browser and 8x8 meetings/video..obviously, gpu.ploinks/puddle........puddle is the cpu of the blackwell system for cuda-q.

Your Recent History

Delayed Upgrade Clock